News

A response to this week’s CDC article on Lyme disease. By Patricia Smith, Lyme Disease Association, June 14, 2017:   The time has come when the public is entitled to know who in government or elsewhere is controlling the treatment of Lyme disease. 43 years into the... Read More »

This week, CDC employees published an article about five patients who had “adverse effects” after undergoing “unproven” treatments for Lyme disease. What they failed to disclose, however, is that their report was based on questionable research conducted by the CDC–research... Read More »

Our thanks to Fox5NY, for creating this public service announcement about Lyme disease. “The Faces of Lyme” showcases the work of photographer Stephanie Michelle Vandagriff, who has at times taken pictures at LymeDisease.org events. (Most recently, at our MyLymeData... Read More »

They call him Ötzi the Iceman. He lived and died 5300 years ago, in the Eastern Alps near the modern-day border of Austria and Italy. His frozen remains were discovered accidentally by German hikers in 1991. Now, his mummified body rests at the South Tyrol Museum of Archaeology... Read More »

Press release from LymeDisease.org, June 8, 2017: A new study suggests that developing effective treatments for Lyme disease may depend on understanding which patients respond to different treatments. Data collected from over 3,400 patients through LymeDisease.org‘s... Read More »

LymeDisease.org board member Dr. Christine Green was among the speakers at our recent MyLymeData conference in the San Francisco Bay Area. Dr. Green has developed an expertise in treating Lyme disease over a 30-year span of practicing integrative, complementary, and... Read More »

According to the experts, ticks and the diseases they carry are expanding into new geographic areas. While the majority of Americans have heard of Lyme disease, fewer than 2% have any knowledge of another tick-borne disease called ehrlichiosis. (1, 2) As a matter of fact, my own... Read More »

A new Canadian study finds that antibiotics can slow the progress of multiple sclerosis (MS). The study, published in the New England Journal of Medicine, used minocycline to treat early relapsing remitting MS. The annual cost of treatment with antibiotics ($600) is substantially... Read More »

Our CEO Lorraine Johnson spoke with Lyme Ninja Radio recently. She revealed surprising statistics of how many people use antibiotics, as well as our big data project MyLymeData. MyLymeData is not only accelerating research, but it’s also empowering patients to pool data and... Read More »